Randall Moreadith, Chief Scientific Officer at Serina Therapeutics, Inc. (SER), sold 3,398 shares at $4.24 ($14K) on 2025-11-05, disclosed to the SEC on 2025-11-06.
Open-market sale of $14k SER by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| SER | SELL | 2026-02-03 | $20K | — | Filing → |
| SER | SELL | 2026-01-29 | $23K | — | Filing → |
| SER | SELL | 2026-01-23 | $7K | — | Filing → |